Nature's Truth GABA, 750 mg, 60 Quick Release Capsules
UPC: 840093113870
Nature's Truth GABA 750 mg is a single-ingredient supplement designed to provide a straightforward dose of gamma-aminobutyric acid. The manufacturer describes it as a quick-release capsule intended for daily use, with a suggested intake of one capsule one to two times daily, preferably with meals. They note it may help with occasional stress, though this statement has not been evaluated by the FDA.
This product delivers 750 mg of GABA per serving, a dosage that aligns with common supplement ranges for this amino acid neurotransmitter. The capsules are formulated without artificial colors, flavors, sweeteners, or preservatives, and the brand highlights its Non-GMO and Gluten-Free certifications. The supplement comes in a 60-count bottle, providing a one- to two-month supply based on the recommended usage.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| GABA (Gamma-Aminobutyric Acid) | 750 mg | * |
| † Daily Value not established | ||
Other Ingredients
Gelatin capsule, vegetable magnesium stearate, silica, rice powder.
Free of gluten, wheat, yeast, milk, lactose, soy, artificial color, artificial flavor, artificial sweetener, preservatives.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
For adults, take one (1) quick release capsule one to two times daily, preferably with a meal.
Warning
Not intended for use by persons under the age of 18. If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use. If any adverse reactions occur, immediately stop using this product and consult your doctor. If seal under cap is damaged or missing, do not use. Keep out of reach of children. Store in a cool, dry place.
Product Info
- Brand
- Nature's Truth
- UPC
- 840093113870
- Package Qty
- 60 count
- Dimensions
- 4.3 x 1.95 x 1.95 in
- Shipping Weight
- 0.17 lb
- First Available
- 03/2022





